Sascha Alvermann

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients

Stefan Gingele, Thais Langer Jacobus, Franz Felix Konen et al. · Cells · 2018 · 133 citations · Full text

Clinical Immunology, Cell Therapy, T-regulatory Cell +19

Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients

Martin W. Hümmert, Ulrich Wurster, Lena Bönig et al. · Frontiers in Immunology · 2019 · 26 citations · Full text

Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen

Stefan Gingele, Martin W. Hümmert, Sascha Alvermann et al. · Frontiers in Neurology · 2019 · 23 citations · Full text

Immunophenotyping of cerebrospinal fluid cells by Chipcytometry

Martin W. Hümmert, Sascha Alvermann, Stefan Gingele et al. · Journal of Neuroinflammation · 2018 · 18 citations · Full text